Functional analysis of the emerging roles for the KISS1/KISS1R signaling pathway in cancer metastasis

Zhenxi Li; Jing Liu; Hiroyuki Inuzuka; Wenyi Wei

doi:10.1016/j.jgg.2021.10.005

Volume 49 Issue 3

Mar. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2022 > 49(3): 181-184

PDF( 929 KB)

Functional analysis of the emerging roles for the KISS1/KISS1R signaling pathway in cancer metastasis

doi: 10.1016/j.jgg.2021.10.005

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA

Funds:

We apologize for not citing all relevant reports owing to space limitations.

Received Date: 2021-07-07
Accepted Date: 2021-10-06
Rev Recd Date: 2021-10-05
Publish Date: 2021-11-10

Abstract

Abstract

Cancer metastasis, a process that primary tumor cells disseminate to secondary organs, is the most lethal and least effectively treated characteristic of human cancers. Kisspeptins are proteins encoded by the KISS1 gene that was originally described as a melanoma metastasis suppressor gene. Then, Kisspeptins were discovered as the natural ligands of the G-protein-coupled receptor 54 (GPR54) that is also called KISS1R. The KISS1/KISS1R signaling is essential to control GnRH secretion during puberty and to establish mammalian reproductive function through the hypothalamic-pituitary-gonadal (HPG) axis. Although KISS1 primarily plays a suppressive role in the metastasis progression in several cancer types, emerging evidence indicates that the physiological effect of KISS1/KISS1R in cancer metastasis is tissue context-dependent and still controversial. Here, we will discuss the epigenetic mechanism involved in the regulation of KISS1 gene expression, the context-dependent role of KISS1/KISS1R, prometastasis/anti-metastasis signaling pathways of KISS1/KISS1R, and the perspective anticancer therapeutics via targeting KISS1/KISS1R.
- KISS1/KISS1R,
- Metastasis,
- Anticancer therapeutics

FullText(HTML)

References(30)

References

Blake, A., Dragan, M., Tirona, R.G., Hardy, D.B., Brackstone, M., Tuck, A.B., Babwah, A.V.,Bhattacharya, M., 2017. G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance. Sci Rep 7, 46525

Chen, S.Q., Chen, Z.H., Lin, S.Y., Dai, Q.B., Fu, L.X.,Chen, R.Q., 2014. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients. World J Gastroenterol 20, 10071-10081

Chen, S., Chen, W., Zhang, X., Lin, S.,Chen, Z., 2016. Overexpression of KiSS-1 reduces colorectal cancer cell invasion by downregulating MMP-9 via blocking PI3K/Akt/NF-kappaB signal pathway. Int J Oncol 48, 1391-1398

Cho, S.G., Li, D., Stafford, L.J., Luo, J., Rodriguez-Villanueva, M., Wang, Y.,Liu, M., 2009. KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem 107, 1139-1149

Cho, S.G., Wang, Y., Rodriguez, M., Tan, K., Zhang, W., Luo, J., Li, D.,Liu, M., 2011. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Res 71, 6535-6546

Ciaramella, V., Della Corte, C.M., Di Mauro, C., Tomassi, S., Di Maro, S., Troiani, T., Martinelli, E., Bianco, R., Cosconati, S., Pierantoni, R., et l., 2018. Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells. Oncotarget 9, 19273-19282

Ciccone, M., Calin, G.A.,Perrotti, D., 2015. From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies. Front Oncol 5, 21

Corno, C.,Perego, P., 2019. KiSS1 in regulation of metastasis and response to antitumor drugs. Drug Resist Updat 42, 12-21

Cvetkovic, D., Dragan, M., Leith, S.J., Mir, Z.M., Leong, H.S., Pampillo, M., Lewis, J.D., Babwah, A.V.,Bhattacharya, M., 2013. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells. Endocrinology 154, 1999-2014

Evans, B.J., Wang, Z., Mobley, L., Khosravi, D., Fujii, N., Navenot, J.M.,Peiper, S.C., 2008. Physical association of GPR54 C-terminal with protein phosphatase 2A. Biochem Biophys Res Commun 377, 1067-1071

Goldberg, S.F., Miele, M.E., Hatta, N., Takata, M., Paquette-Straub, C., Freedman, L.P.,Welch, D.R., 2003. Melanoma metastasis suppression by chromosome 6:evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 63, 432-440

Guzman, S., Brackstone, M., Radovick, S., Babwah, A.V.,Bhattacharya, M.M., 2018. KISS1/KISS1R in Cancer:Friend or Foe? Front Endocrinol (Lausanne) 9, 437

Guzman, S., Brackstone, M., Wondisford, F., Babwah, A.V.,Bhattacharya, M., 2019. KISS1/KISS1R and Breast Cancer:Metastasis Promoter. Semin Reprod Med 37, 197-206

Ji, K., Ye, L., Ruge, F., Hargest, R., Mason, M.D., Jiang, W.G., 2014. Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer. BMC Cancer 14, 723

Kim, J.N., Kim, T.H., Yoon, J.H.,Cho, S.G., 2018. Kisspeptin Inhibits Colorectal Cancer Cell Invasiveness by Activating PKR and PP2A. Anticancer Res 38, 5791-5798

Liu, C., Wang, L., Li, Y.W., Cui, Y.S., Wang, Y.Q.,Liu, S., 2019. Long noncoding RNA LUCAT1 promotes migration and invasion of prostate cancer cells by inhibiting KISS1 expression. Eur Rev Med Pharmacol Sci 23, 3277-3283

Liu, G., Zhao, X., Zhou, J., Cheng, X., Ye, Z.,Ji, Z., 2018. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway. Cell Physiol Biochem 48, 371-384

Lomniczi, A., Loche, A., Castellano, J.M., Ronnekleiv, O.K., Bosch, M., Kaidar, G., Knoll, J.G., Wright, H., Pfeifer, G.P.,Ojeda, S.R., 2013. Epigenetic control of female puberty. Nat Neurosci 16, 281-289

Ly, T., Harihar, S.,Welch, D.R., 2020. KISS1 in metastatic cancer research and treatment:potential and paradoxes. Cancer Metastasis Rev 39, 739-754

Makri, A., Pissimissis, N., Lembessis, P., Polychronakos, C.,Koutsilieris, M., 2008. The kisspeptin (KiSS-1)/GPR54 system in cancer biology. Cancer Treat Rev 34, 682-692

Marot, D., Bieche, I., Aumas, C., Esselin, S., Bouquet, C., Vacher, S., Lazennec, G., Perricaudet, M., Kuttenn, F., Lidereau, R., et l., 2007. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr Relat Cancer 14, 691-702

Popa, S.M., Clifton, D.K.,Steiner, R.A., 2008. The role of kisspeptins and GPR54 in the neuroendocrine regulation of reproduction. Annu Rev Physiol 70, 213-238

Qiu, J.J., Lin, X.J., Tang, X.Y., Zheng, T.T., Zhang, X.Y.,Hua, K.Q., 2020. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1. Int J Cancer 146, 2588-2598

Shen, Z.L., Wang, B., Jiang, K.W., Ye, C.X., Cheng, C., Yan, Y.C., Zhang, J.Z., Yang, Y., Gao, Z.D., Ye, Y.J., et l., 2016. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling. Oncotarget 7, 35092-35105

Stathaki, M., Stamatiou, M.E., Magioris, G., Simantiris, S., Syrigos, N., Dourakis, S., Koutsilieris, M.,Armakolas, A., 2019. The role of kisspeptin system in cancer biology. Crit Rev Oncol Hematol 142, 130-140

Szereszewski, J.M., Pampillo, M., Ahow, M.R., Offermanns, S., Bhattacharya, M.,Babwah, A.V., 2010. GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Galpha(q/11) and beta-arrestin-dependent manner. PLoS One 5, e12964

Ulasov, I., Borovjagin, A., Fares, J., Yakushov, S., Malin, D., Timashev, P.,Lesniak, M.S., 2020. MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases. Cancer Lett 481, 24-31

Zhang, Y., Huang, Z., Zhu, Z., Zheng, X., Liu, J., Han, Z., Ma, X.,Zhang, Y., 2014. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1. PLoS One 9, e104252

Vazquez, M.J., Toro, C.A., Castellano, J.M., Ruiz-Pino, F., Roa, J., Beiroa, D., Heras, V., Velasco, I., Dieguez, C., Pinilla, L., et l., 2018. SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression. Nat Commun 9, 4194

Zhang, Y.X., Cui, H.X., Liu, L.,Yi, G.K., 2019. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1. Eur Rev Med Pharmacol Sci 23, 6045-6052

Relative Articles

Supplements(0)

Cited By

Proportional views